Skip to main content

Circulating Tumor Cells Market Sales And Industry Forecasts Till, 2014 - 2024

The growth of the circulating tumor cells (CTC) market is influenced by the increasing mortality rate due to cancer, several types of genetic disorders, drastic changes in lifestyle, an increase in smoking-causing disorders, and a rise in consumption of alcohol. Moreover, developments in bioengineering technologies, biomedical imaging, and the rise in demand for preventive medications for different types of cancers are also stimulating the market growth of circulating tumor cells. However, the factors restraining the market growth comprise the significant cost of detection techniques, scarcity of specific biomarkers for the detection of CTCs, reluctance in the adoption of new technologies, and other technical limits.

Download Free Sample  - https://www.millioninsights.com/industry-reports/circulating-tumor-cells-ctc-market/request-sample

The increasing focus of the market players for the introduction of companion diagnostics for cancer and other disorders and the increase in demand for research projects on cancer are a few trends in the circulating tumor cells industry. The circulating tumor cells market is categorized based on technology, application, and geography. Based on technology, the market is divided into CTC Detection, CTC Enrichment, and CTC Analysis. CTC enrichment segment is expected to lead the market owing to high efficiency due to increased functionalities.

Based on application, the circulating tumor cells (CTC) industry is divided into tumorigenesis research, cancer stem cell research, EMT biomarkers development, and others.EMT biomarkers development segment is predicted to hold the maximum share of the market due to advancements in technology. In terms of end-user, the circulating tumor cells (CTC) market is bifurcated into research & academic institutes, hospitals & clinics, and diagnostic centers. The hospitals and clinics segment is expected to hold a larger share of the market due to the increasing preference for efficient treatment offered at hospitals.

Geographically, the CTC industry is segmented as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America, followed by Europe accounted for the larger share of the market due to a large number of market players and mature healthcare infrastructure. Asia-Pacific is also expected to grow considerably in the coming years due to increasing investment and growing technological advancements in the domain.

The prominent players in the circulating tumor cells industry include ApoCell, Advanced Cell Diagnostics, Inc, ClearbridgeBiomedicsPte Ltd, Aviva Biosciences, CynvenioBiosystems, Inc, BioceptInc, MiltenyiBiotec, Menarini Silicon Biosystems, Qiagen, and CreatvMicrotech Inc.

Comments

Popular posts from this blog

Global Real-time Rendering Solutions Market Analysis, Trends and Future Prospects, 2023

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Real-time Rendering Solutions Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). Download free PDF sample copy @  https://www.radiantinsights.com/research/global-real-time-rendering-solutions-market-research-report-2019-2023/request-sample In this report, the global Real-time Rendering Solutions market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023. The report firstly introduced the Real-time Rendering Solutions basics: definitions, classifications, applicatio...

What are the key end-use segments in the global Decoquinate-Based Products industry?

Decoquinate (ethyl 6-decoxy-7-ethoxy-4-oxo-1H-quinoline-3-carboxylate) is an antiprotozoal agent. It acts against coccidia parasites and is thus known as a coccidiostat. Decoquinate-based products are majorly used in veterinary medicine. The global decoquinate-based products market is segmented based on the type of formulation, and geography.  Decoquinate acts on the sporozoite stage of a coccidian parasite’s lifecycle. The sporozoite can penetrate the host’s intestinal call and prevents their further development, which necessitates the use of antiprotozoal substances. Decoquinate has low toxicity and is administered orally to a wide range of mammalian and avian species. Various studies conducted on decoquinate-based products suggest that the drug is readily tolerated by several target species including cattle and lambs. On the other hand, studies conducted on rats and dogs showed minor changes in food consumption, feed conversion, subdued behavior, and changes in body weight and o...

Knowledge Process Outsourcing (KPO) Market Trends, Opportunity And Forecast 2014 - 2025

The global Knowledge Process Outsourcing (KPO) market size was valued at USD 28.94 billion in 2016 and is anticipated to reach USD 124.29 billion by 2025. The huge availability of data is one of the key factors that have enabled the growth as it needs to be analyzed and processed. The KPO market also observed the transformation of the market into a consultative model. Though, rules set by several governments regarding compliance and legal clauses are one of the major challenges faced by the global KPO market. With global perceptions on outsourcing business activities, companies are looking for more specialist and analytical expertise, hence KPOs are seen to be gradually fulfilling such requirement of enterprises that are keen to outsource third party service providers. With competitive market scenario and increasing globalization the time for commercialization of services and products are thinning down. For example, in BFSI capital markets, with the modification in demand for complex g...